https://www.massdevice.com/edwards-plans-to-spin-off-critical-care-business-next-year/
Link to Edwards future plans. The following bit looks interesting -
"Edwards anticipates CE mark for its Sapien M3 TMTT device by the end of 2025. It plans to complete early enrollment in an aortic stenosis treatment trial in early 2024. The company expects EARLY TAVR data studying aortic stenosis patients at TCT 2024."
Further Update on Edwards
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.75 |
Change
-1.200(6.02%) |
Mkt cap ! $360.4M | |||
| Open | High | Low | Value | Volume |
| $20.00 | $20.00 | $18.75 | $143.6K | 7.561K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $18.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.78 | 518 | 1 |
View Market Depth
| Last trade - 15.58pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.01 |
Change
-1.200 ( 4.85 %) |
||||
| Open | High | Low | Volume | ||
| $19.75 | $19.75 | $19.01 | 464 | ||
| Last updated 11.04am 17/06/2024 ? | |||||
| AVR (ASX) Chart |
